Determinants of mortality following a diagnosis of prostate cancer in Veterans Affairs and private sector health care systems.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 14534226.
- Also identified by PMC identifier 1448038.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We compared patterns of mortality among men with prostate cancer at 2 Department of Veterans Affairs (VA) and 2 private-sector hospitals in the Chicago area. Mortality rates for 864 cases diagnosed between 1986 and 1990 were estimated using Cox proportional hazards models that incorporated age; income; cancer stage, differentiation, and treatments; and baseline comorbidity. Race tended to associate with all-cause mortality irrespective of health care setting (Blacks vs Whites: hazard rate ratio [HRR] = 1.68 [95% confidence interval (CI) = 1.06, 2.67]; P <.001 in the private sector; HRR = 1.50 [95% CI = 0.94, 2.38]; P =.088 in the VA). However, comorbidity determined risk in the VA, whereas age and income predicted risk in the private sector. Determinants of all-cause mortality in men with prostate cancer vary according to health care setting.
Medical subject headings
- Black or African American
- Hospital Mortality
- Hospitals, Private
- Hospitals, University
- Hospitals, Veterans
- Prostatic Neoplasms
- White People